Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition.

Goodall, Jane

Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition. [electronic resource] - Cancer discovery 09 2017 - 1006-1017 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article

2159-8290

10.1158/2159-8290.CD-17-0261 doi


Antineoplastic Agents--therapeutic use
Cell-Free Nucleic Acids--blood
Gene Frequency
Humans
Male
Mutation
Phthalazines--therapeutic use
Piperazines--therapeutic use
Poly(ADP-ribose) Polymerase Inhibitors--therapeutic use
Prognosis
Prostatic Neoplasms--blood
Exome Sequencing